People regularly exposed to ‘forever chemicals’ are at greater risk of developing type 2 diabetes compared to those rarely ...

A new study published in The New England Journal of Medicine showed that daily dapagliflozin dramatically reduced the risk of ...

A randomized controlled trial investigated use of sodium glucose cotransporter 2 inhibitors (SGLT2i) on top of standard care immunosuppression in lupus nephritis.

Adults who feel anxious on a Monday have greater long-term stress hormone levels, regardless of their working status, new research has highlighted. A recent study from the University of Hong Kong has ...

The Maryland Prescription Drug Affordability Board (PDAB) found that Eli Lilly and Boehringer Ingelheim’s Jardiance (empagliflozin) and AstraZeneca’s Farxiga (dapagliflozin) present affordability ...

AstraZeneca posted $14.46 billion in Q2 revenue, reaffirming its 2025 outlook as the FDA advances Imfinzi in gastric cancer.

Included in the open-label crossover SOGALDI-PEF study were adults with symptomatic heart failure (New York Heart Association ...

India accounts for 1 in 7 adults living with diabetes globally. An estimated 89.8 million adults aged 20-79 years in India ...

The data from 2019 to 2023 show rapid uptake of the drugs alongside wide patient- and practice-level variations.

Combining insulin treatment with the investigational drug dapagliflozin may improve health outcomes for adolescents with type ...

Combining insulin treatment with the investigational drug dapagliflozin may improve health outcomes for adolescents with type 1 diabetes, according to ...

A new clinical trial shows that combining dapagliflozin with insulin improves kidney health and blood sugar control, and ...